Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-qs9v7 Total loading time: 0 Render date: 2024-07-10T21:19:06.690Z Has data issue: false hasContentIssue false

Chapter 4 - The Epidemiology of Cannabis Use and Cannabis Use Disorder

from Part II - The Changing Face of Cannabis

Published online by Cambridge University Press:  12 May 2023

Deepak Cyril D'Souza
Affiliation:
Staff Psychiatrist, VA Connecticut Healthcare System; Professor of Psychiatry, Yale University School of Medicine
David Castle
Affiliation:
University of Tasmania, Australia
Sir Robin Murray
Affiliation:
Honorary Consultant Psychiatrist, Psychosis Service at the South London and Maudsley NHS Trust; Professor of Psychiatric Research at the Institute of Psychiatry
Get access

Summary

Cannabis is among the most widely-used substances worldwide. Because cannabis use can incur some harms to health, understanding the prevalence of cannabis use and cannabis use disorder in the general population and how this has changed over time is an important public health priority. The prevalence of cannabis use varies widely across countries, demographic characteristics, and time. However, prevalence is consistently highest among young adults. Rates are generally higher in males, although this may be changing in younger US cohorts. Across regions, prevalence rates of past-year cannabis use were lowest in Asian countries and some countries in Central and South America, and intermediate in Australia, New Zealand, and many European countries. Highest prevalences and greatest increases over time were found in adult participants in recent surveys in North America, including the United States and Canada, where public perception of risk in cannabis use is decreasing. Cannabis use disorder is defined by the same criteria that are used to define other substance use disorders. The risk of cannabis use disorder among adult cannabis users is now much higher than it was in the early 1990s, ranging from 20–33% of users, depending on their frequency of use.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Virginia: American Psychiatric Association.Google Scholar
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Virginia: American Psychiatric Association.Google Scholar
Anthony, J. C., Warner, L. A., and Kessler, R. C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol, 2, 244268.Google Scholar
Asbridge, M., Hayden, J. A., and Cartwright, J. L. (2012). Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis. BMJ, 344, e536.Google Scholar
Azofeifa, A., Mattson, M. E., Schauer, G., et al. (2016). National estimates of marijuana use and related indicators: National Survey on Drug Use and Health, United States, 2002–2014. Morbid Mortal Week Rep (MMWR), 65, 128.Google ScholarPubMed
Benedetti, E., Resce, G., Brunori, P., et al. (2021). Cannabis policy changes and adolescent cannabis use: Evidence from Europe. Int J Environ Res Public Health, 18, 5174.Google Scholar
Bollom, A., Austrie, J., Hirsch, W., et al. (2018). Emergency department burden of nausea and vomiting associated with cannabis use disorder: US trends from 2006 to 2013. J Clin Gastroenterol, 52, 778783.Google Scholar
Bonn-Miller, M. O., Harris, A. H., and Trafton, J. A. (2012). Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. Psychol Serv, 9, 404416.CrossRefGoogle ScholarPubMed
Brady, J. E., and Li, G. (2014). Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999–2010. Am J Epidemiol, 179, 692699.Google Scholar
Carliner, H., Mauro, P. M., Brown, Q. L., et al. (2017). The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002–2014. Drug Alcohol Depend, 170, 5158.Google Scholar
Centers for Disease Control and Prevention. (2015). International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Available at: www.cdc.gov/nchs/icd/icd9cm.htm (Last accessed 17 October 2021).Google Scholar
Centers for Disease Control and Prevention. (2021). International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM). Available at: www.cdc.gov/nchs/icd/icd10cm.htm (Last accessed 17 October 2021).Google Scholar
Chan, G., Chiu, V., Sun, T., et al. (2021). Age-related trends in cannabis use in Australia. Findings from a series of large nationally representative surveys. Addict Behav, 123, 107059.Google Scholar
Charilaou, P., Agnihotri, K., Garcia, P., et al. (2017). Trends of cannabis use disorder in the inpatient: 2002 to 2011. Am J Med, 130, 678687 e7.Google Scholar
Compton, W. M., Grant, B. F., Colliver, J. D., et al. (2004). Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA, 291, 21142121.Google Scholar
Compton, W. M., Han, B., Jones, C. M., et al. (2016). Marijuana use and use disorders in adults in the USA, 2002–14: Analysis of annual cross-sectional surveys. Lancet Psychiatry, 3, 954964.Google Scholar
Compton, W. M., Han, B., Jones, C. M., et al. (2019). Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. Drug Alcohol Depend, 204, 107468.Google Scholar
Degenhardt, L., & Hall, W. (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet, 379, 5570.Google Scholar
Denis, C. M., Gelernter, J., Hart, A. B., et al. (2015). Inter-observer reliability of DSM-5 substance use disorders. Drug Alcohol Depend, 153, 229235.Google Scholar
Englund, A., Freeman, T. P., Murray, R. M., et al. (2017). Can we make cannabis safer? Lancet Psychiatry, 4, 643648.Google Scholar
Gajendran, M., Sifuentes, J., Bashashati, M., et al. (2020). Cannabinoid hyperemesis syndrome: Definition, pathophysiology, clinical spectrum, insights into acute and long-term management. J Invest Med, 68, 13091316.Google Scholar
Ghasemiesfe, M., Ravi, D., Vali, M., et al. (2018). Marijuana use, respiratory symptoms, and pulmonary function: A systematic review and meta-analysis. Ann Intern Med, 169, 106115.Google Scholar
Goodman, S., Wadsworth, E., Leos-Toro, C., et al. (2020). Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Int J Drug Policy, 76, 102658.Google Scholar
Grant, B. F. (1996). Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: Results of the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse, 8, 195210.Google Scholar
Grant, B. F. (1997). Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: Results of the National Longitudinal Alcohol Epidemiologic Survey. J Stud Alcohol, 58, 464473.Google Scholar
Grant, B. F., Chu, A., Sigman, R., et al. (2014). Source and Accuracy Statement: National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism. Available at: www.niaaa.nih.gov/sites/default/files/NESARC_Final_Report_FINAL_1_8_15.pdf (Last accessed 10 October 2021).Google Scholar
Grant, B. F., Goldstein, R. B., Saha, T. D., et al. (2015a). Epidemiology of DSM-5 alcohol use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry, 72, 757766.Google Scholar
Grant, B. F., Goldstein, R. B., Smith, S. M., et al. (2015b). The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): Reliability of substance use and psychiatric disorder modules in a general population sample. Drug Alcohol Depend, 148, 2733.Google Scholar
Grant, B. F., Moore, T. C., Shepard, J., et al. (2003). Source and Accuracy Statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism.Google Scholar
Grant, B. F., Stinson, F. S., Dawson, D. A., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry, 61, 807816.Google Scholar
Grucza, R. A., Agrawal, A., Krauss, M. J., et al. (2016a). Declining prevalence of marijuana use disorders among adolescents in the United States, 2002 to 2013. J Am Acad Child Adolesc Psychiatry, 55, 487494 e6.Google Scholar
Grucza, R. A., Agrawal, A., Krauss, M. J., et al. (2016b). Recent trends in the prevalence of marijuana use and associated disorders in the United States. JAMA Psychiatry, 73, 300301.Google Scholar
Gutkind, S., Fink, D. S., Shmulewitz, D., et al. Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults. Drug Alcohol Depend. 2021 Dec 1;229(Pt B):109137.Google Scholar
Hall, W., and Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use. Lancet, 374, 13831391.Google Scholar
Han, B., Compton, W. M., Jones, C. M., et al. (2017). Cannabis use and cannabis use disorders among youth in the United States, 2002–2014. J Clin Psychiatry, 78, 14041413.Google Scholar
Hartman, R. L., Brown, T. L., Milavetz, G., et al. (2015) Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend, 154, 2537.Google Scholar
Hartman, R. L., and Huestis, M. A. (2013). Cannabis effects on driving skills. Clin Chem, 59, 478492.Google Scholar
Hasin, D., Samet, S., Nunes, E., et al. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry, 163, 689696.Google Scholar
Hasin, D., Shmulewitz, D., Stohl, M., et al. (2020). Test–retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview. Drug Alcohol Depend, 216, 108294.CrossRefGoogle ScholarPubMed
Hasin, D. S., and Aharonovich, E. (2020). Implications of medical and recreational marijuana laws for neuroscience research: A review. Curr Behav Neurosci Rep, 7, 258266.Google Scholar
Hasin, D. S., Greenstein, E., Aivadyan, C., et al. (2015a) The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): Procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug Alcohol Depend, 148, 4046.Google Scholar
Hasin, D. S., Kerridge, B. T., Saha, T. D., et al. (2016). Prevalence and correlates of DSM-5 cannabis use disorder, 2012–2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry, 173, 588599.CrossRefGoogle ScholarPubMed
Hasin, D. S., O’Brien, C. P., Auriacombe, M., et al. (2013). DSM-5 criteria for substance use disorders: Recommendations and rationale. Am J Psychiatry, 170, 834851.Google Scholar
Hasin, D. S., Saha, T. D., Kerridge, B. T., et al. (2015b). Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry, 72, 12351242.Google Scholar
Johnston, L. D., Miech, R. A., O’Malley, P. M., et al. (2020). Demographic Subgroup Trends among Adolescents in the Use of Various Licit and Illicit Drugs, 1975–2019. Ann Arbor, MI: Institute for Social Research, University of Michigan. Available at: www.monitoringthefuture.org/pubs/occpapers/mtf-occ94.pdf (Last accessed 17 October 2021).Google Scholar
Kerr, W. C., Lui, C., and Ye, Y. (2018). Trends and age, period and cohort effects for marijuana use prevalence in the 1984–2015 US National Alcohol Surveys. Addiction, 113, 473481.Google Scholar
Koob, G. F., and Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24, 97129.Google Scholar
Lenne, M. G., Dietze, P. M., Triggs, T. J., et al. (2010). The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand. Accid Anal Prev, 42, 859866.Google Scholar
Leung, J., Chan, G. C. K., Hides, L., et al. (2020). What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addict Behav, 109, 106479.CrossRefGoogle ScholarPubMed
Li, M. C., Brady, J. E., DiMaggio, C. J., et al. (2012). Marijuana use and motor vehicle crashes. Epidemiol Rev, 34, 6572.Google Scholar
Livne, O., Shmulewitz, D., Lev-Ran, S., et al. (2019). DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults. Drug Alcohol Depend, 195, 170177.Google Scholar
Manthey, J. (2019). Cannabis use in Europe: Current trends and public health concerns. Int J Drug Policy, 68, 9396.Google Scholar
McKay, M. P., and Groff, L. (2016). 23 years of toxicology testing fatally injured pilots: Implications for aviation and other modes of transportation. Accid Anal Prev, 90, 108117.Google Scholar
Miech, R. A., Johnston, L. D., O’Malley, P. M., et al. (2021). Monitoring the Future National Survey Results on Drug Use, 1975–2020: Volume I, Secondary School Students. Ann Arbor, MI: Institute for Social Research, University of Michigan. Available at: www.monitoringthefuture.org/pubs/monographs/mtf-vol1_2020.pdf (Last accessed 17 October 2021).Google Scholar
Miech, R. A., Patrick, M. E., O’Malley, P. M., et al. (2020). Trends in reported marijuana vaping among US adolescents, 2017–2019. JAMA, 323, 475476.Google Scholar
Millar, S. R., Mongan, D., O’Dwyer, C., et al. (2021). Correlates of patterns of cannabis use, abuse and dependence: Evidence from two national surveys in Ireland. Eur J Public Health, 31, 441447.Google Scholar
National Institute on Drug Abuse. (2021). Monitoring the Future. Available at: www.drugabuse.gov/drug-topics/trends-statistics/monitoring-future (Last accessed 18 October 2021).Google Scholar
Naveed, S., Waqas, A., Chaudhary, A. M. D., et al. (2020). Prevalence of common mental disorders in south Asia: A systematic review and meta-regression analysis. Frontiers in Psychiatry, 11, 573150.Google Scholar
O’Neill-Dee, C., Spiller, H. A., Casavant, M. J., et al. (2020). Natural psychoactive substance-related exposures reported to United States poison control centers, 2000–2017. Clin Toxicol, 58, 813820.Google Scholar
OECD and The World Bank. (2020). Health at a Glance: Latin America and the Caribbean 2020. Available at: www.oecd-ilibrary.org/content/publication/6089164f-en (Last accessed 22 October 2021).Google Scholar
Public Health England, Home Office, Welsh Government, The Scottish Government, Public Health Wales & Department of Health (Northern Ireland). (2021). United Kingdom Drug Situation: Focal Point annual report. Available at: www.gov.uk/government/publications/united-kingdom-drug-situation-focal-point-annual-report (Last accessed 22 October 2021).Google Scholar
Richards, J. R. (2018). Cannabinoid hyperemesis syndrome: Pathophysiology and treatment in the emergency department. J Emerg Med, 54, 354363.Google Scholar
Rigucci, S., Marques, T. R., Di Forti, M., et al. (2016). Effect of high-potency cannabis on corpus callosum microstructure. Psychol Med, 46, 841854.CrossRefGoogle ScholarPubMed
Rogeberg, O., and Elvik, R. (2016). The effects of cannabis intoxication on motor vehicle collision revisited and revised. Addiction, 111, 13481359.Google Scholar
Santaella-Tenorio, J., Levy, N. S., Segura, L. E., et al. (2019). Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002–2016. Drug Alcohol Depend, 205, 107621.Google Scholar
Sarvet, A. L., Wall, M. M., Keyes, K. M., et al. (2018). Recent rapid decrease in adolescents’ perception that marijuana is harmful, but no concurrent increase in use. Drug Alcohol Depend, 186, 6874.Google Scholar
Shi, Y. (2017). Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. Drug Alcohol Depend, 173, 144150.Google Scholar
Singh, J. A. (2022). Time-trends in hospitalizations with cannabis use disorder: A 17-year U.S. national study. Subst Abus, 43, 408414.Google Scholar
Sofuoglu, M., Sugarman, D. E., and Carroll, K. M. (2010). Cognitive function as an emerging treatment target for marijuana addiction. Exp Clin Psychopharmacol, 18, 109119.Google Scholar
Strand, M. C., Gjerde, H., and Morland, J. (2016). Driving under the influence of non-alcohol drugs: An update. Part II: Experimental studies. Forensic Sci Rev, 28, 79101.Google Scholar
Substance Abuse and Mental Health Services Administration. (2020). 2019 NSDUH Detailed Tables. Available at: www.samhsa.gov/data/report/2019-nsduh-detailed-tables (Last accessed 15 October 2021).Google Scholar
United Nations Office on Drugs and Crime. (2020). UNODC World Drug Report 2020: Global Drug Use Rising; while COVID-19 Has Far Reaching Impact on Global Drug Markets. Vienna: United Nations Office on Drugs and Crime.Google Scholar
United Nations Office on Drugs and Crime. (2021). World Drug Report 2021. Available at: www.unodc.org/res/wdr2021/field/WDR21_Booklet_3.pdf (Last accessed 17 October 2021).Google Scholar
University of Michigan. (2021). Monitoring the Future. Available at: www.monitoringthefuture.org/ (Last accessed 17 October 2021).Google Scholar
Volkow, N. D., Swanson, J. M., Evins, A. E., et al. (2016). Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review. JAMA Psychiatry, 73, 292297.Google Scholar
Wadsworth, E., and Hammond, D. (2019). International differences in patterns of cannabis use among youth: Prevalence, perceptions of harm, and driving under the influence in Canada, England & United States. Addict Behav, 90, 171175.Google Scholar
Watson, T. M., and Mann, R. E. (2016). International approaches to driving under the influence of cannabis: A review of evidence on impact. Drug Alcohol Depend, 169, 148155.Google Scholar
World Health Organization. (2016). International Statistical Classification of Diseases and Related Health Problems, 10th ed. Available at: https://icd.who.int/browse10/2016/en (Last accessed 15 October 2021).Google Scholar
World Health Organization. (2021). Cannabis. Available at: www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis (Last accessed 17 October 2021).Google Scholar
Zhu, H., and Wu, L. T. (2016). Trends and correlates of cannabis-involved emergency department visits: 2004 to 2011. J Addict Med, 10, 429436.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×